scispace - formally typeset
S

Sabine Schulz

Researcher at Helmholtz Zentrum München

Publications -  17
Citations -  1403

Sabine Schulz is an academic researcher from Helmholtz Zentrum München. The author has contributed to research in topics: Mitochondrion & Mitochondrial permeability transition pore. The author has an hindex of 14, co-authored 17 publications receiving 1166 citations.

Papers
More filters
Journal ArticleDOI

Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease

TL;DR: It is suggested that the mitochondrion constitutes a pivotal target of copper in Wilson disease, and copper-chelating agents reversed mitochondrial accumulation of copper, as well as signs of intra-mitochondrial membrane crosslinking, thereby preserving the functional and structural integrity of mitochondria.
Journal ArticleDOI

Radiation–Induced Signaling Results in Mitochondrial Impairment in Mouse Heart at 4 Weeks after Exposure to X-Rays

TL;DR: This is the first study showing the biological alterations in the murine heart mitochondria several weeks after the exposure to low- and high-dose of ionizing radiation, and it is proposed that these first pathological changes lead to an increased risk of cardiovascular disease after radiation exposure.
Journal ArticleDOI

Methanobactin reverses acute liver failure in a rat model of Wilson disease

TL;DR: It is demonstrated that ATP7B-deficient rats recapitulate WD-associated phenotypes, including hepatic copper accumulation, liver damage, and mitochondrial impairment, and methanobactin treatment prevented hepatocyte death, subsequent liver failure, and death in the rodent model, suggesting that MB has potential as a therapeutic agent for the treatment of acute Wilson disease.
Journal ArticleDOI

Mode of Cell Death Induction by Pharmacological Vacuolar H+-ATPase (V-ATPase) Inhibition

TL;DR: It is concluded that archazolid leads to energy stress which activates adaptive mechanisms like autophagy mediated by HIF1α and finally leads to apoptosis which is proposed as a promising drugable target in cancer therapy caught up at the interplay of apoptosis, Autophagy, and cellular/metabolic stress.